UK 157147
Alternative Names: UK-157,147; UK-15747Latest Information Update: 11 Mar 2008
At a glance
- Originator Pfizer
- Class Antiasthmatics
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alopecia; Asthma
Most Recent Events
- 27 Sep 2000 Pfizer has licensed the electrohydrodynamic pulmonary delivery technology of Battelle Pulmonary Therapeutics
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 07 Dec 1999 Clinical trials in Asthma in United Kingdom (Inhalation)